n-methylaspartate has been researched along with sch 23390 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jardemark, K; Marcus, MM; Shahid, M; Svensson, TH | 1 |
| Coccurello, R; Mele, A; Oliverio, A | 1 |
| Björkholm, C; Jardemark, K; Malmerfelt, A; Marcus, MM; Nyberg, S; Schilström, B; Svensson, TH | 1 |
3 other study(ies) available for n-methylaspartate and sch 23390
| Article | Year |
|---|---|
Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: involvement of dopamine D1 receptors.
Topics: Animals; Antipsychotic Agents; Benzazepines; Dibenzocycloheptenes; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Heterocyclic Compounds, 4 or More Rings; In Vitro Techniques; Male; Membrane Potentials; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate | 2010 |
Dopamine-glutamate interplay in the ventral striatum modulates spatial learning in a receptor subtype-dependent manner.
Topics: 2-Amino-5-phosphonovalerate; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Basal Ganglia; Behavior, Animal; Benzazepines; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Exploratory Behavior; Glutamic Acid; Habituation, Psychophysiologic; Learning; Male; Mice; Motor Activity; N-Methylaspartate; Quinoxalines; Receptors, Dopamine; Space Perception; Sulpiride | 2012 |
Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Antipsychotic Agents; Avoidance Learning; Benzazepines; Dibenzothiazepines; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Male; Membrane Potentials; Morpholines; N-Methylaspartate; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Prefrontal Cortex; Pyramidal Cells; Quetiapine Fumarate; Raclopride; Rats; Reboxetine | 2013 |